{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:03:39Z","timestamp":1790229819515,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Analyse the implementation of the 6 Principles of Care (PoC) for primary immunodeficiencies (PIDs) in Latin America and the Caribbean countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>Data was extracted from the IPOPI PID Life Index, an interactive tool measuring how it is to live with a PID in the 13 countries in Latin America and the Caribbean (Argentina, Bolivia, Brazil, Chile, Ecuador, El Salvador, Honduras, Mexico, Paraguay, Peru, Puerto Rico, Uruguay and Venezuela).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Care for PIDs in the region varies greatly. Low diagnostic rates and limited diagnostic test options are a reality for the region. Almost all countries provide certain therapies for the treatment of PIDs, mostly anti-infectious therapies, immunoglobulin replacement therapies and vaccines. Biological therapies and curative treatments are less frequent in the countries covered. Universal health coverage for people living with PIDs remains heterogeneous and incomplete. Specialised centres and registries are also heterogeneously implemented. National organisations representing patients with PIDs exist in almost all countries, mainly focussing on general and medical awareness raising, and patient support through social activities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion and conclusion<\/jats:title>\n                    <jats:p>PID care in Latin America and the Caribbean is steadily becoming a reality for many people living with PID. There have been significant improvements in terms of diagnosis, treatment and care in the region over the past decades. Still, there are significant inequalities across the different countries for the 6 PoCs for PID analysed. Joint efforts of medical specialists and patient organizations must continue to ensure an optimal environment for people living with PIDs in the region.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1922796","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:37:33Z","timestamp":1790228253000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Appraisal of primary immunodeficiencies in Latin America and the Caribbean using the IPOPI PID Life Index \u2013 where are we now?"],"prefix":"10.3389","volume":"17","author":[{"given":"Leire","family":"Solis","sequence":"first","affiliation":[{"name":"International Patient Organisation for Primary Immunodeficiencies (IPOPI)","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Anido de Pena","sequence":"additional","affiliation":[{"name":"International Patient Organisation for Primary Immunodeficiencies (IPOPI)","place":["Brussels, Belgium"]},{"name":"Asociaci\u00f3n de Ayuda al Paciente con Inmunodeficiencia Primaria (AAPIDP)","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adli","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Faculty of Medicine, University Kebangsaan Malaysia","place":["Kuala Lumpur, Malaysia"]},{"name":"Clinical Immunology, Hospital Tunku Ampuan Besar Tuanku Aishah Rohani, University Kebangsaan Malaysia (UKM) Specialist Children\u2019s Hospital, Universiti Kebangsaan Malaysia","place":["Kuala Lumpur, Malaysia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Condino-Neto","sequence":"additional","affiliation":[{"name":"Senior Professor of Immunology, Institute of Biomedical Sciences, University of Sao Paulo","place":["Sao Paulo, SP, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nizar","family":"Mahlaoui","sequence":"additional","affiliation":[{"name":"International Patient Organisation for Primary Immunodeficiencies (IPOPI)","place":["Brussels, Belgium"]},{"name":"French National Reference Center for Primary Immune Deficiencies (CEREDIH), Necker Enfants Malades University Hospital, Assistance Publique-H\u00f4pitaux de Paris (APHP)","place":["Paris, France"]},{"name":"Pediatric Immuno-Haematology and Rheumatology Unit, Necker Enfants Malades University Hospital, Assistance Publique-H\u00f4pitaux de Paris (APHP)","place":["Paris, France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Regairaz","sequence":"additional","affiliation":[{"name":"Immunology Unit, Children\u00b4s Hospital Sor Maria Ludovica","place":["Buenos Aires, Argentina"]},{"name":"Department of Immunology, Faculty of Medicine, Universidad Nacional La Plata","place":["Buenos Aires, Argentina"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"S\u00e1nchez-Ram\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, Institute of Laboratory Medicine and IdISSC, Hospital Cl\u00ednico San Carlos","place":["Madrid, Spain"]},{"name":"Department of Immunology, Ophthalmology and Otolaryngology (ENT), School of Medicine, Complutense University","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Prando","sequence":"additional","affiliation":[{"name":"Faculdades Pequeno Pr\u00edncipe","place":["Curitiba, PR, Brazil"]},{"name":"Hospital Pequeno Pr\u00edncipe","place":["Curitiba, PR, Brazil"]},{"name":"Instituto de Pesquisa Pel\u00e9 Pequeno Pr\u00edncipe","place":["Curitiba, PR, Brazil"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Prevot","sequence":"additional","affiliation":[{"name":"International Patient Organisation for Primary Immunodeficiencies (IPOPI)","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Pergent","sequence":"additional","affiliation":[{"name":"International Patient Organisation for Primary Immunodeficiencies (IPOPI)","place":["Brussels, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cecilia","family":"Poli","sequence":"additional","affiliation":[{"name":"Programa de Immunogen\u00e9tica e Imunolog\u00eda Translacional, Instituto de Ciencias e Innovaci\u00f3n en Medicina, Unidad de Inmunologia y Reumatologia, Facultad de Medicina Cl\u00ednica Alemana- Universidad del Desarrollo","place":["Santiago, Chile"]},{"name":"Unidad de Inmunologia y Reumatologia, Hospital Roberto del Rio","place":["Santiago, Chile"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250002","article-title":"The 2024 update of IUIS phenotypic classification of human inborn errors of immunity","volume":"1","author":"Bousfiha","year":"2025","journal-title":"J Hum Immun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.70962\/jhi.20250003","article-title":"Human inborn errors of immunity: 2024 update on the classification from the International Union of Immunological Societies Expert Committee","volume":"1","author":"Poli","year":"2025","journal-title":"J Hum Immun"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00627","article-title":"Primary immune deficiencies \u2013 principles of care","volume":"5","author":"Chapel","year":"2014","journal-title":"Front Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.780140","article-title":"The PID principles of care: Where are we now? A global status report based on the PID Life Index","volume":"12","author":"Nordin","year":"2021","journal-title":"Front Immunol"},{"key":"B5","article-title":"Carga economica de inmunodeficiencias primarias estimada por evidencia de vida real en el Instituto Nacional de Pediatr\u00eda","volume":"43","author":"Bustamante Orgando","year":"2022","journal-title":"Acta Pediatr M\u00e9x"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1151335","article-title":"Primary immunodeficiencies (PID) life index in Southeast Asia: A comparative analysis of PID principles of care (PoC)","author":"Chan","year":"","journal-title":"Front Immunol"},{"key":"B7","unstructured":"Population, total - Latin America & Caribbean\n          \n          \n          \n          2024"},{"key":"B8","volume-title":"Health at a Glance: Latin America and the Caribbean 2023","year":"2023"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-021-02161-0","article-title":"The PID Life Index: An interactive tool to measure the status of the PID healthcare environment in any given country","volume":"17","author":"Sol\u00eds","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.02987","article-title":"Newborn screening for primary immunodeficiencies: The gaps, challenges, and outlook for developing countries","volume":"10","author":"El-Sayed","year":"2020","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.21926\/obm.genet.2303190","article-title":"Newborn screening for severe combined immunodeficiency","volume":"7","author":"Deal","year":"2023","journal-title":"OBM Genet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.635482","article-title":"Editorial: The complexity of primary antibody deficiencies","volume":"12","author":"Quinti","year":"2021","journal-title":"Front Immunol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s13223-024-00938-z","article-title":"Inborn errors of immunity (primary immunodeficiencies)","volume":"20","author":"Kim","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"key":"B14","article-title":"WHO Model List of Essential Medicines, 24th List","year":"2025"},{"key":"B15","unstructured":"The Selection and Use of Essential Medicines, 2025. WHO Model List of Esssential Medicines for Children, 10th list. World Health Organization\n          \n          \n          10.2471\/B09475\n          \n          2025"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01538-z","article-title":"Immunoglobulin replacement therapy during COVID-19 pandemic: Practical and psychological impact in patients with antibody deficiency","volume":"43","author":"Maimaris","year":"2023","journal-title":"J ClinImmunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.625753","article-title":"Primary immunodeficiencies: A decade of progress and a promising future","volume":"11","author":"Meyts","year":"2021","journal-title":"Front Immunol"},{"key":"B18","unstructured":"Vaccines and immunization"},{"key":"B19","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s10875-024-01822-6","article-title":"The Latin American society for immunodeficiencies registry","volume":"45","author":"Seminario","year":"2025","journal-title":"J ClinImmunol"},{"key":"B20","unstructured":"Tracking Universal Health Coverage: 2025 Global Monitoring Report - Conference Edition (English)\n          \n          2025"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-017-0401-y","article-title":"Advances in the care of primary immunodeficiencies (PIDs): From birth to adulthood","volume":"37","author":"Mahlaoui","year":"2017","journal-title":"J ClinImmunol"},{"key":"B22","unstructured":"Pid Life Index"},{"key":"B23","unstructured":"Resolution adopted by the General Assembly on addressing the challenges of persons living with a rare disease and their families\n          \n          \n          \n          2025"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1922796\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:37:36Z","timestamp":1790228256000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1922796\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":23,"alternative-id":["10.3389\/fimmu.2026.1922796"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1922796","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]},"article-number":"1922796"}}